Antiplatelet therapy: A double-edged sword in head injury?

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Beynon, Christopher ^a   Sakowitz, Oliver W ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

BRAIN DAMAGE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; GLASGOW OUTCOME SCALE; HUMAN; NEUROPROTECTION; NOTE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SECONDARY PREVENTION; THROMBOCYTE TRANSFUSION; TRAUMATIC BRAIN INJURY; CRANIOCEREBRAL TRAUMA; FEMALE; MALE;

CRANIOCEREBRAL TRAUMA; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS;

EID: 84876492464     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12597     Document Type: Note

References (10)

1. Fabbri A, Servadei F, Marchesini G, Bronzoni C, Montesi D, Arietta L,. Societa Italiana di Medicina d'Emergenza Urgenza Study group Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study. Crit Care 2013, 17:R53. 10.1186/cc12575, 23514619, Societa Italiana di Medicina d'Emergenza Urgenza Study group.
2. Beynon C, Hertle DN, Unterberg AW, Sakowitz OW. Clinical review: Traumatic brain injury in patients receiving antiplatelet medication. Crit Care 2012, 16:228.
3. Batchelor JS, Grayson A. A meta-analysis to determine the effect of preinjury antiplatelet agents on mortality in patients with blunt head trauma. Br J Neurosurg 2013, 27:12-18. 10.3109/02688697.2012.705361, 22900511.
4. Russolillo A, Di Minno MND, Tufano A, Prisco D, Di Minno G. Filling the gap between science & clinical practice: prevention of stroke recurrence. Thromb Res 2012, 129:3-8. 10.1016/j.thromres.2011.08.012, 21907395.
5. Major J, Reed MJ. A retrospective review of patients with head injury with coexistent anticoagulant and antiplatelet use admitted from a UK emergency department. Emerg Med J 2009, 26:871-876. 10.1136/emj.2008.068643, 19934132.
6. Harr JN, Moore EE, Johnson J, Chin TL, Wohlauer MV, Maier R, Cuschieri J, Sperry J, Banerjee A, Silliman CC, Sauaia A. Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients. Crit Care Med 2013, 41:399-404. 10.1097/CCM.0b013e31826ab38b, 23263579.
7. Crisanti P, Leon A, Lim DM, Omri B. Aspirin prevention of NMDA-induced neuronal death by direct protein kinase Czeta inhibition. J Neurochem 2005, 93:1587-1593. 10.1111/j.1471-4159.2005.03157.x, 15935075.
8. Dorhout Mees SM, Van den Bergh WM, Algra A, Rinkel GJE. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage. Stroke 2008, 39:2186-2187. 10.1161/?STROKEAHA.107.509257, 18467651.
9. Laroche M, Kutcher ME, Huang MC, Cohen MJ, Manley GT. Coagulopathy after traumatic brain injury. Neurosurgery 2012, 70:1334-1345. 10.1227/NEU.0b013e31824d179b, 22307074.
10. Schwarzmaier SM, Kim S-W, Trabold R, Plesnila N. Temporal profile of thrombogenesis in the cerebral microcirculation after traumatic brain injury in mice. J Neurotrauma 2010, 27:121-130. 10.1089/neu.2009.1114, 19803784.